CSF2 and neoplasm: The tumor drug STINGVAX is established by means of the granulocyte‐macrophage colony‐stimulating factor (GM‐CSF) with bacterial or assembled CDNs.164 Therapy of STINGVAX actuated anti‐tumor immune responses in numerous tumor models.164 STINGVAX coupled with ML‐RRS2‐CDA, an objectively structured phosphodiesterase‐resistant c‐di‐AMP (CDA) diastereomer with the phosphate joined linkage as cGAMP, has indicated improved antitumor adequacy contrasted with canonical c‐di‐AMP.